CDER Creates New Biosimilars Resources for Educators, Teaching Facilities

[FDA]

CDER Office of Therapeutic Biosimilars and Biosimilars (OTBB) released its first-ever curriculum toolkit for educators to help students in healthcare professional degree programs improve their understanding of biosimilar and interchangeable products and their regulatory approval pathway in the U.S.


Baca selengkapnya di : http://www.fda.gov...